Noetic Fund II LP: Noetic Launches Second Fund to Invest in Emergent Psychedelic Medicine Sector
Having successfully launched one of the first funds operating in the nascent psychedelic medicine space, Toronto-based venture capital firm Noetic is now launching a second, larger Fund.
TORONTO, ON / ACCESSWIRE / March 4, 2021 / The Noetic Funds, founded by the team at Grey House Partners GP Inc., has announced the launch of Noetic Fund II LP ( Fund II ), a venture capital fund that is seeking to raise a minimum of $200mm to invest in early-stage psychedelic and Central Nervous System focused companies addressing global ailments such as mental health conditions, substance use disorders and distinct inflammatory related ailments. The team will build on its investment thesis validated in Noetic Psychedelic Fund LP ( Fund I ), which has provided exceptional returns to date.